Verition Fund Management LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$14,740,120
+36.9%
127,070
+38.5%
0.17%
+19.4%
Q2 2023$10,769,337
+43.6%
91,732
-2.0%
0.14%
+38.5%
Q1 2023$7,497,139
+17.5%
93,644
+16.2%
0.10%
+4.0%
Q4 2022$6,382,042
+35.2%
80,561
-40.5%
0.10%
+88.7%
Q3 2022$4,719,715
+31.3%
135,304
+147.2%
0.05%
-25.4%
Q2 2022$3,594,000
+73.3%
54,744
+75.7%
0.07%
+184.0%
Q1 2022$2,074,000
-61.0%
31,166
-59.1%
0.02%
-34.2%
Q4 2021$5,324,000
+54.4%
76,114
+15.2%
0.04%
+26.7%
Q3 2021$3,448,000
+172.8%
66,045
+255.4%
0.03%
+172.7%
Q2 2021$1,264,000
-76.5%
18,581
-73.4%
0.01%
-82.0%
Q1 2021$5,381,000
+15.6%
69,847
-9.9%
0.06%
+48.8%
Q4 2020$4,653,000
+92.9%
77,544
+38.4%
0.04%
-14.6%
Q3 2020$2,412,000
-12.4%
56,029
-15.7%
0.05%
-47.3%
Q2 2020$2,754,000
-25.9%
66,486
-22.7%
0.09%
-38.1%
Q1 2020$3,718,000
+177.5%
85,990
+255.4%
0.15%
+512.5%
Q4 2019$1,340,000
-44.2%
24,192
-65.0%
0.02%
-63.6%
Q3 2019$2,403,000
-4.8%
69,194
+10.4%
0.07%
-7.0%
Q2 2019$2,523,00062,6500.07%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q1 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 1,095,407$71,924,0006.79%
ACT CAPITAL MANAGEMENT, LLC 59,000$3,874,0005.42%
S Squared Technology, LLC 108,215$7,105,0004.92%
Redmile Group, LLC 1,898,545$124,658,0004.76%
First Light Asset Management, LLC 595,612$39,108,0004.55%
Soleus Capital Management, L.P. 214,482$14,083,0002.20%
SILVERARC CAPITAL MANAGEMENT, LLC 105,277$6,912,0002.13%
Artal Group S.A. 500,000$32,830,0001.75%
Nicholas Investment Partners, LP 227,877$14,962,0001.41%
Avoro Capital Advisors LLC 1,075,000$70,585,0001.40%
View complete list of KRYSTAL BIOTECH INC shareholders